Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide▪

Autor: Moldovan Loomis, Cristina, Dutzar, Benjamin, Ojala, Ethan W, Hendrix, Lee, Karasek, Charlie, Scalley-Kim, Michelle, Mulligan, Jenny, Fan, Pei, Billgren, Jens, Rubin, Vanessa, Boshaw, Heidi, Kwon, Gayle, Marzolf, Sam, Stewart, Erica, Jurchen, David, Pederson, Susan M, Perrino McCulloch, Lisa, Baker, Brian, Cady, Roger K, Latham, John A, Allison, Dan, Garcia-Martinez, Leon F

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; April 2019, Vol. 369 Issue: 1 p26-36, 11p

\Seven Steps for Singers.

Autor: Rubin, Vanessa

Publikováno v: Downbeat. Feb2008, Vol. 75 Issue 2, p88-88. 2/3p. 1 Color Photograph.

A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.

Autor: Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Czartoski J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Wan YH; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Homad LJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Rubin V; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Glantz H; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Neradilek M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Seydoux E; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., MacCamy AJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Feng J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Mize G; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., De Rosa SC; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Finzi A; Centre de Recherche du CHUM, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada., Lemos MP; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Cohen KW; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Moodie Z; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., McElrath MJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., McGuire AT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Mar 10. Date of Electronic Publication: 2021 Mar 10.